Robert Doebele

Insider Reports History

Location
8000 Jarvis Avenue, Suite 204, Newark, CA
Signature
/s/ Jessica Oien, Attorney-in- Fact for Robert Doebele.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Doebele:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rain Oncology Inc. President, Chief Scientific Officer Common Stock, par value $0.001 per share 0 $0 $1.21 Jan 26, 2024 Direct
Boundless Bio, Inc. Chief Medical Officer Stock Option 180K Feb 3, 2025 Direct
Rain Oncology Inc. President, Chief Scientific Officer Stock Option (Right to Buy) 0 Jan 26, 2024 Direct

Insider Reports Filed by Robert Doebele

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BOLD Boundless Bio, Inc. Feb 3, 2025 1 $0 4 Feb 3, 2025 Chief Medical Officer
BOLD Boundless Bio, Inc. Feb 3, 2025 0 $0 3 Feb 3, 2025 Chief Medical Officer
RAIN Rain Oncology Inc. Jan 26, 2024 13 $0 4 Jan 26, 2024 President, Chief Scientific Officer
RAIN Rain Oncology Inc. Aug 9, 2023 2 $0 4 Aug 11, 2023 President, Chief Scientific Officer
RAIN Rain Oncology Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 President, Chief Scientific Officer
RAIN Rain Therapeutics Inc. Jul 6, 2022 2 $15.4K 4 Jul 7, 2022 President, Chief Scientific Officer
RAIN Rain Therapeutics Inc. Apr 13, 2022 2 $11.9K 4 Apr 15, 2022 President, Chief Scientific Officer
RAIN Rain Therapeutics Inc. Mar 31, 2022 2 $7.9K 4 Apr 4, 2022 President, Chief Scientific Officer
RAIN Rain Therapeutics Inc. Jan 7, 2022 1 $0 4 Feb 4, 2022 EVP, Chief Scientific Officer